Releuko - NDC Database
4 records found
Page:
70121-1568 Feb 25, 2022
Releuko 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution by Amneal Pharmaceuticals LLC
Releuko 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution by Amneal Pharmaceuticals LLC
70121-1569 Feb 25, 2022
Releuko 300 ug/ml Intravenous; Subcutaneous Injection, Solution by Amneal Pharmaceuticals LLC
Releuko 300 ug/ml Intravenous; Subcutaneous Injection, Solution by Amneal Pharmaceuticals LLC
70121-1570 Feb 25, 2022
Releuko 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution by Amneal Pharmaceuticals LLC
Releuko 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution by Amneal Pharmaceuticals LLC
70121-1571 Feb 25, 2022
Releuko 480 ug/1.6ml Intravenous; Subcutaneous Injection, Solution by Amneal Pharmaceuticals LLC
Releuko 480 ug/1.6ml Intravenous; Subcutaneous Injection, Solution by Amneal Pharmaceuticals LLC
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.